Universe Pharmaceuticals Inc.

$2.70+6.30%(+$0.16)
TickerSpark Score
58/100
Mixed
84
Valuation
35
Profitability
55
Growth
84
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a UPC research report →

52-Week Range8% of range
Low $2.00
Current $2.70
High $11.00

Companywww.universe-pharmacy.com

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements.

CEO
Gang Lai
IPO
2021
Employees
225
HQ
Ji'An, CN

Price Chart

-55.22% · this period
$9.46$5.86$2.25May 20Nov 18May 20

Valuation

Market Cap
$1.52M
P/E
-0.41
P/S
0.09
P/B
0.03
EV/EBITDA
7.81
Div Yield
0.00%

Profitability

Gross Margin
35.28%
Op Margin
-16.33%
Net Margin
-20.56%
ROE
-6.60%
ROIC
-4.46%

Growth & Income

Revenue
$17.86M · -22.44%
Net Income
$-3,672,055 · 57.92%
EPS
$-1055.75 · 26.49%
Op Income
$-2,915,919
FCF YoY
45.29%

Performance & Tape

52W High
$11.00
52W Low
$2.00
50D MA
$2.85
200D MA
$3.75
Beta
1.58
Avg Volume
8.35K

Get TickerSpark's AI analysis on UPC

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Mar 18, 26Zheng Dingother0
Mar 18, 26Lai Gangother0
Mar 18, 26Liu Baochangother0
Mar 18, 26Pang Jiawenother0
Mar 18, 26Yang Lin (Lydia)other0
Mar 18, 26Yu Yongpingother0
Dec 31, 04HARTON LYNNother0
Dec 31, 04HENRIQUES ADOLFOother0
Dec 31, 04HENRIQUES ADOLFOother0
Dec 31, 04MOORE JACKSON Wother0

Our UPC Coverage

We haven't published any research on UPC yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate UPC Report →

Similar Companies